Fully Autonomous Laboratory Systems Now Operational
#1Ginkgo Bioworks' AMP2 platform, operational since January 2026, represents the first fully autonomous anaerobic biology system at industrial scale β integrating GPT-5-class LLM experimental design with robotic execution across fermentation, strain engineering, and assay readout in a closed feedback loop. This is not a pilot: Ginkgo has explicitly restructured its workforce around this platform, with headcount in bench biology roles declining sharply while automation engineering roles grow. Similar autonomous lab systems are operational at Recursion (OS platform), Valo Health, and several stealth-mode biotech companies backed by a16z Bio and Google Ventures.